Other authors linked GDF-15 to chemotherapy resistance, as in the case of Zheng et al., who showed that TAMs derived from a mouse xenograft model of colorectal cancer secrete high levels of GDF-15 and contribute to the reduced chemosensitivity in colorectal cancer cells by increasing fatty acid oxidation metabolism [148]. This evidence concerns the gene GDF15 and colorectal cancer.